Darwin Global Management, Ltd.
Follow13F filer, CIK 1839209, ST. HELIER, Jersey
Darwin Global Management, Ltd. reported $3,991,376,206 across 5 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.
Accepted , ingested 13F-HR 0001892688-26-000178
- Period
- 2026-09-30
- Reported value
- $3.99B
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 1
Part of the filer group Darwin Global Management, Ltd.
- Darwin Global Master Fund, Ltd.
- Dr. Abhishek Trehan
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| GMABnew | +17,899,876 | $639M |
| ABVXadded | +400,000 | $39.6M |
| BLTEadded | +19,913 | $3.38M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| INSMexited | -6,431,163 | -$674M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001892688-26-000178, largest first. % of portfolio is the value over $3,991,376,206, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INC | 10,629,822 | $2.18B | 54.66% | 0 | Timeline | ||
| GMABGENMAB A/S | 17,899,876 | $639M | 16% | new | Timeline | ||
| BLTEBELITE BIO INC | 3,097,132 | $526M | 13.18% | +19,913 | Timeline | ||
| ABVXABIVAX SA | 4,021,583 | $398M | 9.98% | +400,000 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 6,747,300 | $247M | 6.18% | 0 | Timeline |
Sold out in Q3 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| INSMINSMED INC | 6,431,163 | $674M | shares |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001892688-26-000178 | base | 2026-11-16 |